Results 121 to 130 of about 119,475 (261)

SQUAMOUS CELL CARCINOMA ANTIGEN IN ORAL SQUAMOUS CELL CARCINOMAS

open access: yesSQUAMOUS CELL CARCINOMA ANTIGEN IN ORAL SQUAMOUS CELL CARCINOMAS
Squamous cell carcinoma (SCC) antigen is a tumor-associated antigen isolated from the squamous cell carcinoma of the uterine cervix. In order to estimate the usefulness of the SCC antigen in monitoring the clinical behaviors of oral squamous cell carcinomas, we analyzed clinicopathologically and immunohistochemically 54 cases of squamous cell carcinoma
openaire  

Adipokines in oral squamous cell carcinoma-a narrative overview. [PDF]

open access: yesBDJ Open
Velusamy P   +7 more
europepmc   +1 more source

Superior Labial Artery Mucosal Flap (SLAM) for Reconstruction of Major Lower Lip Mucosal Defects

open access: yesHead &Neck, EarlyView.
ABSTRACT Background The superior labial artery mucosal (SLAM) flap is a versatile, pedicled axial flap ideally suited for mucosal lining in lower lip reconstruction. Methods This article details the surgical anatomy and technique of the SLAM flap, highlighting its role as a standalone liner or mucosal adjunct to microvascular free tissue transfer in ...
Nicholas Shannon   +2 more
wiley   +1 more source

Clinicopathological Significance of Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma. [PDF]

open access: yesInt J Mol Sci
Lequerica-Fernández P   +9 more
europepmc   +1 more source

Risk of Head and Neck Cancer in Former Smokers by Subsite: A Multicenter Analysis From the INHANCE Consortium

open access: yesInternational Journal of Cancer, EarlyView.
Tobacco use and alcohol consumption are primary risk factors for head and neck squamous cell carcinoma, with combined use occurring in three‐quarters of cases. This large international study of former smokers shows that the risk reduction effect of smoking cessation occurs more slowly for laryngeal cancer than for other head and neck cancer subsites ...
Matheus de Abreu   +41 more
wiley   +1 more source

First‐Line Osimertinib in Patients with EGFR‐Mutant Advanced Non‐Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study

open access: yesThe Oncologist, EarlyView., 2021
Abstract Lessons Learned Osimertinib has confirmed effectiveness in this real‐world population of patients with EGFR‐mutant advanced non‐small cell lung cancer. Thromboembolic events occur more frequently than previously reported, suggesting a thrombotic diathesis that requires further investigation. Patients with at least three metastatic sites, brain
Martina Lorenzi   +21 more
wiley   +1 more source

The mechanism of lncRNA PVT1 in oral squamous cell carcinoma. [PDF]

open access: yesFront Oncol
Ren Q   +11 more
europepmc   +1 more source

Effectiveness of Organized Strategies to Enhance Access to Preventive Oral Cancer Screening Among High‐Risk Individuals in Brazil: A Randomized Clinical Trial in Primary Care

open access: yesInternational Journal of Cancer, EarlyView.
This randomized clinical trial evaluated the performance of organized risk‐based strategies to expand access to cancer preventive oral examination among vulnerable populations within the public health system of Rio de Janeiro, Brazil. Compared with an opportunistic approach, the organized invitation‐based oral cancer screening approaches systematically
Marcia Frias Pinto Marinho   +8 more
wiley   +1 more source

RHEBL1 expression is activated by the Oct4-Sox2 complex in oral squamous cell carcinoma. [PDF]

open access: yesFunct Integr Genomics
Qiu F   +8 more
europepmc   +1 more source

The 9th Edition of the UICC TNM Classification of Malignant Tumours: Updates and Rationale for Change

open access: yesInternational Journal of Cancer, EarlyView.
ABSTRACT The standard for assessing and recording the extent of the tumour, a necessity for most malignancies, is the Tumour Node Metastases (TNM) classification. The Union for International Cancer Control (UICC) TNM committee has defined this since the early 1950s.
James D. Brierley   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy